Danaher | DHR - Vertriebs- Und Verwaltungskosten

Aktienkurs
191.12
Täglich Wechseln
0.33 0.17%
Monatlich
-6.32%
Jährlich
-3.43%
Q2 Prognose
185.37




Vertriebs- Und Verwaltungskosten Veränderung Datum
Abbott USD 3.13B 125M 2025-12
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Boston Scientific USD 1.83B 93M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 2.03B 35M 2025-12
Dentsply International USD 383M 28M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
ESCO Technologies USD 61.21M 2.13M 2025-12
Fortive USD 417.4M 10.2M 2025-12
Henry Schein USD 808M 48M 2025-12
Hologic USD 2.5B 2.24B 2025-12
Illumina USD 283M 27M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Keysight Technologies USD 447M 48M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Medtronic 2.97B 159M 2025-09
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Quest Diagnostics USD 504M 3M 2025-12
Quidel USD 194.4M 7.5M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Roper Industries USD 841.6M 11.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Waters USD 240.01M 25.78M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12